Overview

Phase II Dasatinib Study in Advanced Breast Cancer

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if dasatinib will safely reduce the size or spread of your tumor.
Phase:
Phase 2
Details
Lead Sponsor:
Duke University
Collaborator:
Bristol-Myers Squibb
Treatments:
Dasatinib